Guidelines for the clinical management of familial adenomatous polyposis (FAP)
Vasen et al.
Gut 2008;57:704-713.
ABSTRACT
| FULL TEXT
Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation: Potential Implications for Cyclooxygenase-2 Inhibition
Arehart et al.
Circ. Res. 2008;102:986-993.
ABSTRACT
| FULL TEXT
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis
Solomon et al.
Circulation 2008;117:2104-2113.
ABSTRACT
| FULL TEXT
Cyclooxygenase-2 Inhibitors and Most Traditional Nonsteroidal Anti-inflammatory Drugs Cause Similar Moderately Increased Risks of Cardiovascular Disease
Hennekens and Borzak
J CARDIOVASC PHARMACOL THER 2008;13:41-50.
ABSTRACT
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists
Sidiropoulos et al.
Rheumatology (Oxford) 2008;47:355-361.
ABSTRACT
| FULL TEXT
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study
Sieper et al.
Ann Rheum Dis 2008;67:323-329.
ABSTRACT
| FULL TEXT
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
American College of Cardiology/American Heart Asso et al.
J Am Coll Cardiol 2008;51:210-247.
FULL TEXT
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee
Antman et al.
Circulation 2008;117:296-329.
FULL TEXT
Cardiovascular Thromboembolic Adverse Effects Associated with Cyclooxygenase-2 Selective Inhibitors and Nonselective Antiinflammatory Drugs
Joshi et al.
Anesth. Analg. 2007;105:1793-1804.
ABSTRACT
| FULL TEXT
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Hoes et al.
Ann Rheum Dis 2007;66:1560-1567.
ABSTRACT
| FULL TEXT
Emerging Paradigms, Platforms, and Unifying Themes in Biomarker Science
Becker
J Am Coll Cardiol 2007;50:1777-1780.
FULL TEXT
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
Scott et al.
Ann Rheum Dis 2007;66:1296-1304.
ABSTRACT
| FULL TEXT
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:e1-e157.
FULL TEXT
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:652-726.
FULL TEXT
Microsomal Prostaglandin E2 Synthase: A Safer Target than Cyclooxygenases?
Timmers et al.
Mol. Interv. 2007;7:195-199.
ABSTRACT
| FULL TEXT
Human Pharmacology of Naproxen Sodium
Capone et al.
J. Pharmacol. Exp. Ther. 2007;322:453-460.
ABSTRACT
| FULL TEXT
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
Kerr et al.
NEJM 2007;357:360-369.
ABSTRACT
| FULL TEXT
Nonselective Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk: Are They Safe?
Waksman et al.
The Annals of Pharmacotherapy 2007;41:1163-1173.
ABSTRACT
| FULL TEXT
Meta-analysis: Acupuncture for Osteoarthritis of the Knee
Manheimer et al.
ANN INTERN MED 2007;146:868-877.
ABSTRACT
| FULL TEXT
Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
Bardia et al.
JNCI J Natl Cancer Inst 2007;99:881-889.
ABSTRACT
| FULL TEXT
The Cycloxygenase 2 (COX-2) Story: It's Time to Explain, Not Inflame
Salinas et al.
J CARDIOVASC PHARMACOL THER 2007;12:98-111.
ABSTRACT
Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?
Brune and Furst
Rheumatology (Oxford) 2007;46:911-919.
ABSTRACT
| FULL TEXT
Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians: A Scientific Statement From the American Heart Association
Antman et al.
Circulation 2007;115:1634-1642.
FULL TEXT
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study
Rahme and Nedjar
Rheumatology (Oxford) 2007;46:435-438.
ABSTRACT
| FULL TEXT
Cardiovascular Effects of the Cyclooxygenase Inhibitors
White
Hypertension 2007;49:408-418.
FULL TEXT
Cyclooxygenase Inhibitors and Cardiovascular Risk
Andersohn et al.
JAMA 2007;297:586-587.
FULL TEXT
The Adenoma Prevention with Celecoxib and Prevention of Colorectal Sporadic Adenomatous Polyps Trials: Stepping Stones to Progress
Hawk and Viner
Cancer Epidemiol. Biomarkers Prev. 2007;16:185-187.
FULL TEXT
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med. 2007;12:30-30.
FULL TEXT
Pain Management in Elderly Patients
Hix
Journal of Pharmacy Practice 2007;20:49-63.
ABSTRACT
NSAID Trials and the Choice of Comparators -- Questions of Public Health Importance
Psaty and Weiss
NEJM 2007;356:328-330.
FULL TEXT
COX-2 Inhibitors and NSAIDs: More Data on CV Risk
Journal Watch Cardiology 2006;2006:2-2.
FULL TEXT
COX-2 Inhibitors, Other NSAIDs, and Cardiovascular Risk: The Seduction of Common Sense
Graham
JAMA 2006;296:1653-1656.
FULL TEXT